Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Proteus Digital Health

Proteus Digital Health

Proteus Digital Health is a company that creates digital medicines.

Proteus Digital Health is a company that creates digital medicines that obtain and aggregate various behavioral, physiological, and therapeutic metrics.

Proteus is developing a new category of pharmaceuticals—digital medicine. Digital medicine includes drugs that communicate when they have been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making, and data analytics to serve the needs of doctors and health systems. The goal of digital medicine is to empower patients and their families, enable physicians and health systems to more effectively manage risk, and ensure that outcomes are reliably achieved.

Proteus Digital Health is working towards creating smart pills and drugs with sensors inside, which are capable of tracking medication adherence. The ingestible sensors of Proteus transmit a signal to a patch worn on the torso once they get to the stomach, sending a digital record to the mobile phone of patients. With permission, caregivers, and doctors can monitor whether or not medications have been taken remotely through the Proteus cloud.

Timeline

November 30, 2019
Proteus Digital Health raises a $5,000,000 venture round.
February 26, 2016
Proteus Digital Health raises a $110,000,000 series H round from Harbin Pharmaceutical Group Co., Ltd..
July 29, 2014
Proteus Digital Health raises a $172,000,000 series G round.
May 2013
Proteus Digital Health raises a $62,500,000 series F round from Novartis, Otsuka Pharmaceutical and Sino Portfolio.
May 16, 2012
Proteus Digital Health raises a $17,500,000 venture round.
December 31, 2009
Proteus Digital Health raises a $25,400,000 venture round.
August 2, 2008
Proteus Digital Health raises a $28,600,000 series D round from Asset Management Company and Asset Management Ventures.
January 16, 2006
Proteus Digital Health raises a $33,000,000 series C round from Asset Management Company and Asset Management Ventures.

Funding rounds

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Heather Landi
September 3, 2020
FierceHealthcare
Hundreds of startups are trying to make it in a digital health market that is now flush with cash. But a breakthrough technology is not enough to succeed. Here are lessons that startup CEOs can learn from the digital health companies that have hit the mark and those that missed, industry experts say.
Heather Landi
August 20, 2020
FierceHealthcare
Despite 11th-hour objections by some investors, a judge has approved the sale of Proteus Digital Health's assets to a pharmaceutical giant. The company will now be able to exit bankruptcy as part of a deal with Otsuka Pharmaceutical for $15 million, a fraction of its previous valuation.
Heather Landi
August 12, 2020
FierceHealthcare
There is a potential deal on the table for Proteus Digital Health to exit bankruptcy in a $15 million sale to Otsuka Pharmaceutical. In an 11th-hour play, a group of investors including drug giant Novartis are trying to push off that sale.
Heather Landi
July 24, 2020
FierceHealthcare
Proteus Digital Health could exit bankruptcy in a deal with Otsuka Pharmaceutical, one of its main customers. The Silicon Valley company filed for bankruptcy last month and now has a "stalking horse" offer from the Japanese drugmaker's American unit.

References

Golden logo
By using this site, you agree to our Terms & Conditions.